XORTX Therapeutics Income Statement (2020-2026) | XRTX

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
1.70M1.66M1.74M2.28M2.26M2.21M2.18M2.85M2.98M2.98M2.91M9.71M
Revenue & cost
Revenue (Quarter)
2.13M0.97M0.92M2.15M1.36M1.26M0.99M-1.59M
Operating items
Amortization - Intangibles (Quarter)
0.00M0.00M0.01M0.02M0.00M0.04M0.01M-0.00M-0.04M0.01M0.01M0.01M0.01M0.00M
Research & Development (Quarter)
0.03M0.30M0.34M1.52M1.14M1.13M1.40M0.77M0.50M0.42M-1.58M0.03M0.06M0.03M
Wages, Salaries and Other (Quarter)
0.05M0.04M0.11M0.07M0.17M0.04M0.07M0.10M0.16M0.08M-0.29M0.20M0.03M0.31M
Selling, General & Administrative (Quarter)
0.01M0.00M0.12M0.09M0.10M0.09M0.06M0.08M0.07M0.07M-0.14M0.08M0.06M0.06M
Restructuring Costs (Quarter)
0.02M0.03M0.02M0.02M0.04M0.04M0.03M-0.08M0.03M0.02M0.05M
Operating Expenses (Quarter)
0.04M0.31M0.46M1.64M1.27M1.24M1.49M0.88M0.60M0.53M-1.80M0.15M0.14M0.14M
EBIT (Quarter)
-0.70M-0.32M0.31M-2.87M-0.96M-0.88M-1.53M-1.35M-1.26M-1.39M2.90M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Non-operating items
Interest & Investment Income (Quarter)
-0.00M-0.01M-0.03M-0.04M-0.05M-0.05M0.05M0.09M0.04M0.03M0.03M0.02M0.01M0.01M0.00M0.00M
Other Non Operating Income (Quarter)
0.01M-0.01M0.28M0.12M-0.21M-0.39M0.46M-0.01M0.00M-0.00M0.01M-0.01M-0.02M0.01M-0.06M362.000.01M-0.02M865.000.01M
Net income details
EBT (Quarter)
-0.70M-0.32M0.31M-2.87M-0.97M-0.92M-1.58M-1.36M-1.26M-1.39M2.90M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Profit After Tax (Quarter)
-0.22M-6.64M7.21M-2.70M-1.24M-1.20M-2.15M-1.83M-1.69M-1.33M7.02M-3.02M0.17M-0.59M6.75M-0.70M-0.89M-0.65M-4.72M-0.81M
Income from Non-Controlling Interests (Quarter)
0.53M-6.30M9.44M0.33M1.13M0.36M1.58M-1.83M-1.69M-1.33M8.50M-1.72M0.17M0.24M0.87M0.25M-0.72M0.08M0.09M0.01M
Income from Continuing Operations (Quarter)
-0.70M-0.32M0.31M-2.87M-0.97M-0.92M-1.58M-1.36M-1.26M-1.39M2.90M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Consolidated Net Income (Quarter)
-0.70M-0.32M0.31M-2.87M-0.97M-0.92M-1.58M-1.36M-1.26M-1.39M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Income towards Parent Company (Quarter)
-0.70M-0.32M0.31M-2.87M-0.97M-0.92M-1.58M-1.36M-1.26M-1.39M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Net Income towards Common Stockholders (Quarter)
-0.70M-0.32M0.31M-2.87M-0.97M-0.92M-1.58M-1.36M-1.26M-1.39M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Additional items
EPS (Basic) (Quarter)
-3.38-1.541.41-9.96-3.37-3.18-5.35-3.51-3.15-3.49-2.24-2.57-1.510.25-1.29-1.17-0.74-5.520.00
EPS (Diluted) (Quarter)
-3.85-1.541.41-9.96-3.37-3.18-5.35-3.51-3.15-3.49-2.24-2.57-1.510.25-1.67-1.55-0.74-5.52-0.87
Shares Outstanding (Quarter)
0.21M0.21M0.22M0.29M0.29M0.29M0.30M0.39M0.40M0.40M0.40M0.49M0.58M0.58M0.58M0.75M0.76M0.97M0.95M1,392.44M
Shares Outstanding (Diluted) (Quarter)
0.18M0.21M0.22M0.29M0.29M0.29M0.30M0.39M0.40M0.40M0.40M0.49M0.58M0.58M0.58M0.58M0.58M0.97M0.95M0.95M
EBITDA (Quarter)
-0.70M-0.32M0.31M-2.87M-0.96M-0.88M-1.53M-1.35M-1.26M-1.39M2.90M-1.09M-1.49M-0.87M0.14M-0.96M-0.89M-0.72M-5.23M-0.82M
Interest Expenses (Quarter)
-541.00-0.00M-0.00M0.00M0.01M0.04M0.05M0.00M